LRRK2 and Parkinson disease: The substitution of glycine for serine in exon 41 of the protein kinase domain in LRRK2 (G2019S mutation), is the most common mutation, as was estimated by the international LRRK2 consortium, representing 1% of sporadic and 4% of familial PD cases worldwide [3].